Keyword Connections

•  Andries Zijlstra
•  Ashwath Jayagopal
•  Javid Moslehi

•  Nagaraj Nagathihalli
•  Paul Moots
•  Ruey Hu

•  Sudan Loganathan

Resources

• No matching connections

Communities

• HPV-Associated Cancer ConsorTIum at VandErbilt

Publications

• Integrative mathematical oncology.
  Anderson AR, Quaranta V
  (2008) Nat Rev Cancer 8: 227-34
• Optimising surveillance for relapse of Wilms' tumour.
  Lovvorn HN
  (2018) Lancet Oncol 19: 1006-1007
• Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
  Johnson DB, Reynolds KL, Sullivan RJ, Balko JM, Patrinely JR, Cappelli LC, Naidoo J, Moslehi JJ
  (2020) Lancet Oncol 21: e398-e404
• HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.
  Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL
  (2008) Cancer Cell 14: 435-46
• Physician and stakeholder perceptions of conflict of interest policies in oncology.
  Lockhart AC, Brose MS, Kim ES, Johnson DH, Peppercorn JM, Michels DL, Storm CD, Schuchter LM, Rathmell WK
  (2013) J Clin Oncol 31: 1677-82
• Burnout and career satisfaction among US oncologists.
  Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M
  (2014) J Clin Oncol 32: 678-86
• Hospice referral practices for children with cancer: a survey of pediatric oncologists.
  Fowler K, Poehling K, Billheimer D, Hamilton R, Wu H, Mulder J, Frangoul H
  (2006) J Clin Oncol 24: 1099-104
• Factors associated with the career choices of hematology and medical oncology fellows trained at academic institutions in the United States.
  Horn L, Koehler E, Gilbert J, Johnson DH
  (2011) J Clin Oncol 29: 3932-8
• Satisfaction with work-life balance and the career and retirement plans of US oncologists.
  Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ
  (2014) J Clin Oncol 32: 1127-35
• Ethics in oncology: consulting for the investment industry.
  Berlin J, Bruinooge SS, Tannock IF
  (2007) J Clin Oncol 25: 444-6
• Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
  Collichio FA, Kayoumi KM, Hande KR, Hawkins RE, Hawley JL, Adelstein DJ, D'Angelo JM, Stewart JA
  (2009) J Clin Oncol 27: 1706-11
• American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
  Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE
  (2014) J Clin Oncol 32: 1277-80
• Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.
  Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL
  (2019) Circulation 139: e579-e602
• Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension.
  Nazer B, Humphreys BD, Moslehi J
  (2011) Circulation 124: 1687-91
• Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
  Bonaca MP, Olenchock BA, Salem JE, Wiviott SD, Ederhy S, Cohen A, Stewart GC, Choueiri TK, Di Carli M, Allenbach Y, Kumbhani DJ, Heinzerling L, Amiri-Kordestani L, Lyon AR, Thavendiranathan P, Padera R, Lichtman A, Liu PP, Johnson DB, Moslehi J
  (2019) Circulation 140: 80-91
• The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
  Kaufman HL, Kirkwood JM, Hodi FS, Agarwala S, Amatruda T, Bines SD, Clark JI, Curti B, Ernstoff MS, Gajewski T, Gonzalez R, Hyde LJ, Lawson D, Lotze M, Lutzky J, Margolin K, McDermott DF, Morton D, Pavlick A, Richards JM, Sharfman W, Sondak VK, Sosman J, Steel S, Tarhini A, Thompson JA, Titze J, Urba W, White R, Atkins MB
  (2013) Nat Rev Clin Oncol 10: 588-98
• Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
  O'Neil B, Graves AJ, Barocas DA, Chang SS, Penson DF, Resnick MJ
  (2016) J Natl Cancer Inst 108:
• Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.
  Iams WT, Lovly CM
  (2018) Cancer Discov 8: 797-799
• Toward a science of tumor forecasting for clinical oncology.
  Yankeelov TE, Quaranta V, Evans KJ, Rericha EC
  (2015) Cancer Res 75: 918-23
• New insights into tumor microstructure using temporal diffusion spectroscopy.
  Colvin DC, Yankeelov TE, Does MD, Yue Z, Quarles C, Gore JC
  (2008) Cancer Res 68: 5941-7
• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
  Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
  (2020) Ann Oncol 31: 171-190
• Major milestones in translational oncology.
  Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA
  (2016) BMC Med 14: 110
• Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need.
  Moslehi J, Fujiwara K, Guzik T
  (2019) Cardiovasc Res 115: 819-823
• Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
  Hochster HS, Haller DG, de Gramont A, Berlin JD, Philip PA, Moore MJ, Ajani JA
  (2006) Cancer 107: 676-85
• Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
  Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR
  (2017) J Natl Compr Canc Netw 15: 1140-1163
• NCCN Clinical Practice Guidelines Occult primary.
  Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WK, National Comprehensive Cancer Network
  (2011) J Natl Compr Canc Netw 9: 1358-95
• Distress management.
  Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Hoover C, Jacobsen PB, Kvale E, Levy MH, Loscalzo MJ, McAllister-Black R, Mechanic KY, Palesh O, Pazar JP, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, McMillian NR, Freedman-Cass DA
  (2013) J Natl Compr Canc Netw 11: 190-209
• Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
  Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA
  (2018) J Natl Compr Canc Netw 16: 1216-1247
• Melanoma, version 2.2013: featured updates to the NCCN guidelines.
  Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dimaio D, Fleming MD, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, McMillian N, Ho M, National Comprehensive Cancer Network (NCCN)
  (2013) J Natl Compr Canc Netw 11: 395-407
• Non-small cell lung cancer.
  Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM, NCCN (National Comprehensive Cancer Network)
  (2012) J Natl Compr Canc Netw 10: 1236-71
• Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee.
  Eisenburg BL, Alektiar K, Ballo M, DeLaney TF, Ettinger D, Harmon D, Harris J, Joyce M, Kraybill WG, Leider S, Lucas D, Peterson I, Pollock RE, Pritchard D, Schwartz HS, Yasko AW, Pisters PT, Patel SR, watson J, Radiation Therapy Oncology Group
  (2001) Int J Radiat Oncol Biol Phys 51: 53-5
• Thoughts on the future of research, teaching, and testing in the biological sciences of radiation oncology.
  Hallahan DE, Freeman ML
  (2014) Int J Radiat Oncol Biol Phys 88: 1-2
• Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).
  Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S
  (2010) Int J Radiat Oncol Biol Phys 77: 315-6
• Assessing cardiac safety in oncology drug development.
  Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF
  (2019) Am Heart J 214: 125-133
• Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
  Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G
  (2019) Semin Oncol 46: 397-402
• An analysis of concordance among hospital databases and physician records.
  Holt G, Feurer ID, Schwartz HS
  (1998) Ann Surg Oncol 5: 553-6
• Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
  Jagsi R, Spence R, Rathmell WK, Bradbury A, Peppercorn J, Grubbs S, Moy B
  (2014) Oncologist 19: 186-92
• Bladder cancer.
  Borden LS, Clark PE, Hall MC
  (2005) Curr Opin Oncol 17: 275-80
• Current and future trends in imaging informatics for oncology.
  Levy MA, Rubin DL
  (2011) Cancer J 17: 203-10
• Outcomes session.
  Penson DF, Barocas DA, Fleshner N, Sanda MG, Greenfield S
  (2012) Urol Oncol 30: 952-5